Data Transparency in Pharma R&D - Update on Policy 70 and first practical experiences

This seminar will be unique in its kind. It will bring senior experts together in a lively discussion on the status quo of the recent Data Transparency requirements for the pharma industry. General background, legal framework and industry point of view will be presented. Additionally we will have the voice of the patient represented. Breakout sessions in small groups will ensure engagement of the audience in sharing experience, expressing concerns and look for solutions together.

Confirmed Speakers:

  • Sini Eskola, Director Regulatory Affairs, EFPIA
  • Christopher Marschallsay, Head Medical Writing and Public Disclosure, Grünenthal
  • Andy Powrey-Smith, Director Communications, EFPIA  Nele Vanden Cruyce, Stichting Tegen Kanker
  • An Vijverman, Lawyer at Dewallens & partners, ECCRT Trainer

Programme Highlights

  • Data Transparency in Pharma R&D: Setting the scene
  • Update on latest regulations & Policy 70
  • Position of EPFIA
  • Perception from the pharma, results of the EFPIA Survey
  • Patient Perspective to Data Transparency in Pharma R&D
  • Sharing Best Practices: First experiences
  • How do we all benefit from Data Transparency as a patient and as an investigational site

Who Should Attend?
Everyone involved in data transparency within the pharmaceutical industry.
Patient, patient organisations and investigational sites who have an interest in having data transparency for innovative treatment options.



Event Details


Thursday, April 27, 2017 (13:00 h - 18:00 h)


Pullman Hotel Brussels South Station Place Victor Horta 1 - 1060 Brussels - Belgium


€200, excl. VAT (early bird, until 30 March 2017) €250, excl. VAT (after 30 March 2017)



For more info, please contact us on 0032 2 892 40 00 or Register at:


Interested in a regular update of the Life Sciences and biotech sector in Flanders?